Gary D. Novack - Concepedia

Author

Gary D. Novack

Also Known As

Alison Ingram, G D Novack, G NOVACK, G Novack, G. D. Novack, G. Novack, G.D. NOVACK, G.D. Novack, GARY D. NOVACK, GARY NOVACK

425

Publications

6.6K

Citations

H-Index

Concepts

All Affiliations

University of California, Irvine Aerie Pharmaceuticals (United States)Allergan (United States)University of California, Davis Allergan (Ireland)

About

Gary D. Novack is an author at University of California, Irvine specializing in medicine, ophthalmology, and glaucoma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	43	2.5K
2	Engineering	3	3	104
3	Health Sciences	2	2	27
4	Public Health	2	2	82
5	Management	1	1	71

Gary D. Novack

Publications

4.2K

Citations

H-Index

Page 1

	Year	Citations
Vitreous Surgery for Macular Holes Robert Wendel, Arun Patel, N. Kelly, Ophthalmology Ocular DiseaseVitreous BodyOphthalmologySurgeryVitreous Surgery	1993	381
Adherence in Glaucoma: Objective Measurements of Once-Daily and Adjunctive Medication Use Alan L. Robin, Gary D. Novack, David Covert, American Journal of Ophthalmology OphthalmologyExperimental OphthalmologyAdjunctive Medication UseEye HealthGlaucoma	2007	321
Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2) Janet B. Serle, L. Jay Katz, Eugene McLaurin, American Journal of Ophthalmology	2017	260
Two-year multicenter, randomized, double-masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia R. Michael Siatkowski, Susan A. Cotter, R. S. Crockett, Journal of American Association for Pediatric Ophthalmology and Strabismus Ocular DiseaseOphthalmologyExperimental OphthalmologyTwo-year MulticenterParallel Safety	2008	177
Double-masked, Randomized, Dose–Response Study of AR-13324 versus Latanoprost in Patients with Elevated Intraocular Pressure Jason Bacharach, Harvey Dubiner, Brian Levy, Ophthalmology Elevated Intraocular PressureHypertensionOcular DiseaseDose–response StudyOphthalmology	2014	151
Ocular Hypotensive Effect of the Rho Kinase Inhibitor AR-12286 in Patients With Glaucoma and Ocular Hypertension Robert D. Williams, Gary D. Novack, Thomas van Haarlem, American Journal of Ophthalmology HypertensionOcular DiseaseOphthalmologyMedicinePhysiology	2011	130
Memory-enhancing effects of post-training dipivefrin and epinephrine: Involvement of peripheral and central adrenergic receptors Ines B. Introini-Collison, Dara Saghafi, Gary D. Novack, Brain Research Adrenal GlandMemory-enhancing EffectsStress HormoneMedicinePhysiology	1992	115
Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2) Malik Y. Kahook, Janet B. Serle, Francis S. Mah, American Journal of Ophthalmology	2019	114
The Effects of Netarsudil Ophthalmic Solution on Aqueous Humor Dynamics in a Randomized Study in Humans Arash Kazemi, Jay W. McLaren, Casey Kopczynski, Journal of Ocular Pharmacology and Therapeutics	2018	113
Fixed-dose combination of AR-13324 and latanoprost: a double-masked, 28-day, randomised, controlled study in patients with open-angle glaucoma or ocular hypertension Richard A. Lewis, Brian Levy, Nancy Ramirez, British Journal of Ophthalmology	2015	101

Page 1